MedTech Trailblazers

Anyone who's spent time in the medtech field knows that the name Josh Makower is synonymous with innovation, as he has blazed numerous trails for new technologies and therapies alike.

Josh cut his teeth at Pfizer, then went on to become the quintessential entrepreneur, founding eight medtech companies in a variety of clinical specialties including minimally invasive vascular surgery; ear, nose and throat (ENT) issues; and women's health.

He created an incubator, ExploraMed, to bring promising technologies to market and has been and still is a general partner at NEA, a global venture capital firm that funds innovation; and is the incoming director of the Stanford Byers Center for Biodesign.

In this episode, we discover the personality behind the genius and find out what drives his passion and made him who he is today.

Resources

Josh Makower on LinkedIn | Twitter

Casey McGlynn, a founding architect of the MedTech industry, has been guiding and connecting innovators and operators for more than 3 decades. He is a partner at Wilson Sonsini Goodrich & Rosati and has played such a pivotal role in MedTech that the industry would look very different if not for his contributions. He rejoins Andrew Cleeland to share his thoughts on the future of MedTech and further discuss his legacy.

"[What's] so unique about this industry is that [everyone] has this huge drive to help the group that succeeds them," Casey remarks. "That's what's so clean about it. There's nothing shameful in getting rich, but isn't it glorious when you [do it] by helping save lives?... This next generation has a profound opportunity to transform the [areas] we haven't been able to improve in," he adds. Casey talks about the difficulties of entrepreneurship and comments on the need for progression in medical devices.

Resources

Casey McGlynn on LinkedIn

WSGR.com

Casey McGlynn is a partner at Wilson Sonsini Goodrich & Rosati. He is a founding architect of the medtech industry and has been guiding and connecting innovators for more than three decades. Casey has played a pivotal role in the medtech industry: his legacy is so vast that the industry would not be what it is today without his contributions. He joins Andrew Cleeland to talk about his start in the industry and share anecdotes of his early experiences.

Casey explains what drove him to create the Life Sciences Group at Wilson Sonsini Goodrich & Rosati. "I [helped a colleague] start a company… and it really changed my life. In that first year I started two companies… I had to decide whether I was a life science guy, a tech guy, or general, and I chose life science," he remarks. "I felt that the world was just too big... if you wanted to be an expert you had to really get in deep [to] understand." He shares what it was like to begin and advance his career alongside the 'giants' of medtech like Ray Williams, John Simpson and Tom Fogarty.

Resources

Casey McGlynn on LinkedIn

WSGR.com

The field of MedTech uses the latest technology to address medical challenges and find new ways to transform patient care. The industry is filled with groundbreaking experts paving the way to a better and healthier future— transforming patient care and saving countless lives. In this exciting new podcast, Andrew Cleeland invites listeners to tune in as he interviews MedTech professionals about their journeys to success and how their innovative contributions are disrupting and transforming the industry.

Andrew Cleeland welcomes Ginger Graham as the guest in this pilot episode. Ginger Graham is the owner of Ginger & Baker, and Chairman at Clovis Oncology, Inc. She is the former President and CEO of Amylin Pharmaceuticals and also serves on the boards of directors for Walgreen Co., Walgreens Boots Alliance, and several other biotech companies. She joins Andrew Cleeland to share her story - her successes, her failures, her mistakes, and the challenges she overcame. Additionally, she shares lessons she learned along the way and impactful advice that she applied to her personal and professional life.

One such lesson is about maximizing your full potential. We all have a gift in life that is uniquely ours, and the onus is on us to use it to our full ability. We have a responsibility to ourselves and everyone who has supported us to be our best selves.

Resources

Ginger and Baker

Fogarty Innovation

Youtube

Biography:

Ginger began her healthcare career at Eli Lilly, the starting point for many pivotal leaders in our industry. Her career highlights include roles as CEO of Advanced Cardiovascular Systems (ACS); group chairman for the Office of the President at Guidant Corporation as the company launched the world's leading stent platform; and president and CEO of Amylin Pharmaceuticals, a biotech company that she took public.

She currently serves on numerous boards, including Walgreens Boots Alliance, Genomic Health and Elcelyx Therapeutics; and she co-chairs the Scientific Council of the University of Colorado Center for Women's Health Research. She has come full circle as a faculty member at Harvard Business School; an accomplished writer, she has written for the Harvard Business Review and serves on the University of Arkansas Chancellor's Board of Advisors. Ginger is the recipient of numerous awards, including being listed in Pharma VOICE's "100 of the Most Inspiring People," among many others. True to her philanthropic spirit, in her spare time she coaches first-time CEOs in leadership strategy and organization building.

SHOW LESS

Welcome to MedTech Trailblazers where Fogarty Innovation's CEO Andrew Cleeland is talking to the experts and innovators changing the future of healthcare. Find out what this podcast is going to cover, and how it came to be.